Science Daily - Dec 14 8:06 AM

A clear, direct link between obesity and colorectal cancer has been shown in a new analysis. The report shows that obese individuals have a 20% greater risk of developing colorectal cancer compared with those of normal weight. The analyses also indicated that obese men are at 30% greater risk of developing the cancer compared with obese women. Findings from the study also showed that carrying …
Ads by Yahoo!

News-Medical-Net - 5 minutes ago

Abdominal obesity is a strong independent risk factor for heart disease, and using the waist-hip ratio rather than waist measurement alone is a better predictor of heart disease risk among men and women, researchers reported in a study published in Circulation: Journal of the American Heart Association.
Ads by Yahoo!

Medical News Today - Dec 11 4:08 AM

In a paper published December 10, 2007, in the Proceedings of the National Academy of Science (PNAS), Boston University Goldman School of Dental Medicine Associate Dean for Research, Dr. Salomon Amar, and his team have linked obesity to weakened antibacterial immunity. Through experimental research, Amar and his team looked at how control and obese mice fought P. gingivalis infection. [click …
Ads by Yahoo!
Some 400,000 starter kits of diet pill alli (low-dose Xenical) are being shipped to pharmacies, grocery stores and retailers around the United States in preparation for the June 15th launch of the first FDA-approved over-the-counter diet pill.
Alli diet pill has already been approved by FDA and it will be launched on 15th June. Preparations are going on for the launch of over the counter diet pill. 400000 starter kits of Alli diet Pill(low dose Xenical) are shipped to pharmacies, grocery stores and retailers around the United states. according to Glaxo Vice President Greg Westerbeck.The pill is expected to retail for around $60 for a month's supply, based on a patient taking three before-meal pills a day, and Glaxo executives told reporters June 11th that the company is hoping 5 million to 6 million Americans will give the nonprescription diet drug a try.Alli is a half-strength version of prescription diet drug Xenical (orlistat) and works by reducing the amount of fat the body absorbs from food. Undigested fat is eliminated through bowel movements. kept the far-more-costly Xenical from ever becoming a blockbuster.Glaxo executives said they expect most patients to take the diet pill for about three months, though there is no limit on how-long one can remain on the drug.Glaxo has prepared 250 pages of educational materials on alli to accompany the starter pack, and also hopes to sell 200,000 copies of a diet plan and 800,000 copies of a book to help dieters combine alli with a weight-loss program that includes dietary changes and exercise.Read the complete news article here:Dietdrugreport

Next Page »

Drug Test - Dell Latitude D830 Ac Adapter - Urine Detox Drinks - Canadian Homes For Sale - Residence Golf Club